Evidence map›Paper›PMID 36290657›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Biological Effects of Hydrogen Water on Subjects with NAFLD: A Randomized, Placebo-Controlled Trial.

Branislav Kura, Maria Szantova, Tyler W LeBaron, Viliam Mojto, Miroslav Barancik, Barbara Szeiffova Bacova, Barbora Kalocayova, Matus Sykora, Ludmila Okruhlicova, Narcisa Tribulova and 9 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Trial
  3. Associations Between Domestic Water Hardness, Genetic Risk and Severe MASLD: A Large-Scale Cohort Study.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. The Protective Role of Molecular Hydrogen in Ischemia/Reperfusion Injury.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Branislav KuraCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0001-6743-491X
Maria Szantova3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovakia.
Tyler W LeBaronCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
Viliam Mojto3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovakia.
Miroslav BarancikCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
Barbara Szeiffova BacovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0001-8394-7459
Barbora KalocayovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-5283-7561
Matus SykoraCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-0438-3956
Ludmila OkruhlicovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
Narcisa TribulovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-5904-4249
Anna GvozdjakovaPharmacobiochemical Laboratory of 3rd Medical Department, Medical Faculty, Comenius University Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0002-5139-9213
Zuzana SumbalovaPharmacobiochemical Laboratory of 3rd Medical Department, Medical Faculty, Comenius University Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0001-9454-6255
Jarmila KucharskaPharmacobiochemical Laboratory of 3rd Medical Department, Medical Faculty, Comenius University Bratislava, 811 08 Bratislava, Slovakia.
Xenia FaktorovaInternal Clinic of Slovak Medical University, Hospital of St. Michael, 811 08 Bratislava, Slovakia.
Martina Jakabovicova3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovakia.
Zuzana Durkovicová3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovakia.
Jan MacutekMathematical Institute, Slovak Academy of Sciences, 814 73 Bratislava, Slovakia.ORCID 0000-0003-1712-4395
Michaela KoscováMathematical Institute, Slovak Academy of Sciences, 814 73 Bratislava, Slovakia.ORCID 0000-0002-5541-1224
Jan SlezakCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-4217-4493
Slovak Academy of Sciences · SKComenius University Bratislava · SKSlovak Medical University · SKSouthern Utah University · US

Funding

Scientific grant agency of the Ministry of Education of the Slovak Republic VEGA 2/0063/18Slovak Research and Development Agency APVV-0241-11Slovak Research and Development Agency APVV-15-0376Structural funds ITMS 26230120009
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a liver pathology affecting around 25% of the population worldwide. Excess oxidative stress, inflammation and aberrant cellular signaling can lead to this hepatic dysfunction and eventual carcinoma. Molecular hydrogen has been recognized for its selective antioxidant properties and ability to attenuate inflammation and regulate cellular function. We administered hydrogen-rich water (HRW) to 30 subjects with NAFLD in a randomized, double-blinded, placebo-controlled manner for eight weeks. Phenotypically, we observed beneficial trends (p > 0.05) in decreased weight (≈1 kg) and body mass index in the HRW group. HRW was well-tolerated, with no significant changes in liver enzymes and a trend of improved lipid profile and reduced lactate dehydrogenase levels. HRW tended to non-significantly decrease levels of nuclear factor kappa B, heat shock protein 70 and matrix metalloproteinase-9. Interestingly, there was a mild, albeit non-significant, tendency of increased levels of 8-hydroxy-2’-deoxyguanosine and malondialdehyde in the HRW group. This mild increase may be indicative of the hormetic effects of molecular hydrogen that occurred prior to the significant clinical improvements reported in previous longer-term studies. The favorable trends in this study in conjunction with previous animal and clinical findings suggest that HRW may serve as an important adjuvant therapy for promoting and maintaining optimal health and wellness. Longer term studies focused on prevention, maintenance, or treatment of NAFLD and early stages of NASH are warranted.

Indexed as

inflammationmatrix metalloproteinasesmolecular hydrogenNAFLDoxidative stressROS

Identifiers

PMID36290657
PMCPMC9598482
OpenAlexW4297464550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.